Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.5K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Report from the 9th Italian Society for Virology (SIV-ISV) 2025 Annual Meeting.

Viruses·2026
Same author

Humoral and Cellular Immune Response in Patients with Hematological Disorders After Three Doses of mRNA COVID-19 Vaccine: A Single-Center Observational Study.

Vaccines·2026
Same author

Decoding HIV-1 Next Move Through Matrix Protein p17 Quasi-Species.

MicrobiologyOpen·2026
Same author

Small Epidemic Outbreak of Norovirus in the Pediatric Department of Brescia Civic Hospital (Northern Italy): Genomic Characterization and Phylogenetic Analysis.

The Pediatric infectious disease journal·2026
Same author

The Tumor Cell Proliferation Inhibitory Activity of the Human Herpes Virus Type 6 U94 Protein Relies on a Stable Tridimensional Conformation.

Microorganisms·2026
Same author

K5 polysaccharides inhibit SARS-CoV-2 infection by preventing spike-proteolytic priming.

Npj viruses·2026

Related Experiment Video

Updated: Mar 14, 2026

Isolation, Transfection, and Culture of Primary Human Monocytes
09:13

Isolation, Transfection, and Culture of Primary Human Monocytes

Published on: December 16, 2019

14.3K

HIV-1 infection, microenvironment and endothelial cell dysfunction.

Pietro Mazzuca1, Arnaldo Caruso1, Francesca Caccuri1

  • 1Department of Molecular and Translational Medicine, Section of Microbiology, University of Brescia Medical School, Brescia, Italy.

The New Microbiologica
|October 6, 2016
PubMed
Summary
This summary is machine-generated.

Human Immunodeficiency Virus type 1 (HIV-1) infection causes immune activation and vascular dysfunction, even with effective treatment. HIV-1 proteins, not direct viral infection, likely drive endothelial cell (EC) dysfunction through inflammation.

Keywords:
CytokinesEndothelial cellsHIV-1InflammationVascular dysfunctionViral proteins

More Related Videos

Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice
07:23

Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice

Published on: December 20, 2024

1.7K
Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
06:46

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals

Published on: January 5, 2016

18.0K

Related Experiment Videos

Last Updated: Mar 14, 2026

Isolation, Transfection, and Culture of Primary Human Monocytes
09:13

Isolation, Transfection, and Culture of Primary Human Monocytes

Published on: December 16, 2019

14.3K
Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice
07:23

Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice

Published on: December 20, 2024

1.7K
Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
06:46

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals

Published on: January 5, 2016

18.0K

Area of Science:

  • Immunology
  • Virology
  • Cardiovascular Science

Background:

  • HIV-1 infection induces widespread immune activation, affecting both infected and non-infected cells.
  • Endothelial cells (ECs) in HIV-1 positive patients exhibit significant dysfunction, persisting despite current combination antiretroviral therapy (cART).
  • Replication-competent HIV-1 is not found in ECs, suggesting indirect mechanisms for vascular impairment.

Purpose of the Study:

  • To review the mechanisms by which HIV-1 infection contributes to vascular dysfunction.
  • To discuss the role of specific HIV-1 proteins in promoting inflammation and EC dysregulation.
  • To highlight potential therapeutic targets within HIV-1 proteins for managing vascular complications.

Main Methods:

  • Literature review of studies on HIV-1, immune activation, and vascular function.
  • Analysis of in vivo and in vitro data regarding HIV-1's impact on endothelial cells.
  • Examination of the role of viral proteins in disease pathogenesis.

Main Results:

  • HIV-1 infection leads to generalized immune activation and EC dysfunction.
  • Vascular dysfunction in HIV-1+ individuals is likely mediated by inflammatory molecules from infected cells, not direct viral presence in ECs.
  • Specific HIV-1 proteins are implicated in driving inflammation and EC abnormalities.

Conclusions:

  • HIV-1 infection contributes to vascular dysfunction through indirect mechanisms involving inflammatory mediators.
  • Targeting specific HIV-1 proteins offers a potential therapeutic strategy to mitigate HIV-1-associated vascular complications.
  • Understanding these pathways is crucial for improving long-term health outcomes in HIV-1 patients.